Advanced Cancer Nanotechnology & Nanomedicine: Targeted Drug Delivery, Nano-Diagnostics, AI & Clinical Translation

Nanotechnology is transforming cancer diagnosis and treatment by enabling highly targeted drug delivery, early disease detection, improved imaging, and personalized therapeutic strategies. From FDA-approved nanomedicines to next-generation theranostics and smart nanoparticle systems, nanotechnology is redefining the future of precision oncology. This international online workshop provides participants with a comprehensive understanding of nanotechnology applications in cancer diagnosis and therapy. Participants will explore advanced nanoparticle systems, targeted drug delivery strategies, nano-enabled diagnostics, characterization techniques, clinical translation, and regulatory considerations. Through expert-led sessions, virtual case studies, data interpretation, and application-based hands-on activities, participants will gain practical insights into the development and clinical implementation of nanomedicine for cancer management.

This workshop aims to provide participants with a comprehensive understanding of nanotechnology-driven approaches for cancer diagnosis, targeted drug delivery, and precision oncology. It focuses on the design, characterization, and clinical translation of nanomedicine platforms, enabling participants to explore advanced nano-enabled diagnostics, smart drug delivery systems, theranostics, and emerging innovations such as AI-assisted nanomedicine. Through expert-led sessions and application-based hands-on activities, participants will gain practical knowledge required for research, pharmaceutical development, and clinical implementation of cancer nanotherapeutics.

📅Day 1: Fundamentals of Cancer Nanotechnology and Nano-Diagnostics

• Global landscape of cancer diagnosis and the role of nanotechnology in precision oncology Fundamentals of nanomedicine and nanomaterials used in cancer research Types of nanoparticles: Liposomes, Polymeric Nanoparticles, Gold Nanoparticles, Magnetic Nanoparticles, Quantum Dots, Dendrimers, and Lipid Nanoparticles Mechanisms of passive and active targeting in tumor-specific drug delivery Nanotechnology-enabled cancer diagnostics: Liquid biopsy, biosensors, molecular imaging, and contrast agents Clinical applications and FDA-approved nanomedicine products in oncology
• 🛠️ Hands-on Experience
• Hands-on 1 : Explore caNanoLab to search and retrieve published data on FDA-approved nanomedicine products. Identify the nanocarrier type, therapeutic target, and clinical application for each . Hands-on 2 : Use Gallardo BioTools (NanoMisión) — a free browser-based interactive tool — to explore targeted delivery concepts. Compare nanoparticle platforms and select the most suitable nanocarrier for a given cancer type based on drug properties and targeting strategy .

📅Day 2: Nanocarrier Design, Characterization, and Targeted Drug Delivery

• Design principles of nanocarriers for anticancer therapeutics Drug loading strategies and controlled drug release mechanisms Tumor microenvironment-responsive nanocarriers Nanoparticle characterization techniques: Particle size, zeta potential, morphology, encapsulation efficiency, and drug release profiling Quality-by-Design (QbD) principles and regulatory considerations for nanomedicines Challenges in translating laboratory formulations to clinical applications
• 🛠️ Hands-on Experience
• Hands-on 1 : Access the NanoPharos database to retrieve and interpret nanoparticle characterization datasets (particle size, zeta potential, toxicity profiles). Analyze DLS and release kinetics data from published studies . Hands-on 2 : Use MSEP.one (free, open-source molecular editor) to build and simulate a basic nanocarrier design. Evaluate key formulation parameters influencing stability and targeting efficiency .

📅Day 3: Clinical Translation, Emerging Technologies, and Future of Cancer Nanomedicine

• Clinical translation of nanomedicines from laboratory research to patient care Nanotechnology applications in immunotherapy, photothermal therapy, photodynamic therapy, and combination therapies Lipid nanoparticles for nucleic acid and mRNA-based cancer therapeutics AI-assisted nanomedicine design and personalized oncology Regulatory pathways, biosafety, and commercialization of nanotherapeutics Emerging trends: Smart nanorobots, biomimetic nanoparticles, exosome-inspired delivery systems, and theranostics
• 🛠️ Hands-on Experience
• Hands-on 1 : Use TumorXDB (free web platform) to explore pan-cancer multi-omics data. Review clinical trial summaries and evaluate translational challenges of nanomedicine-based cancer therapies . Hands-on 2 : Use Mina — a free LLM for lipid nanoparticles — to explore formulation optimization and predictive modeling. Develop a conceptual translational roadmap for a nanoparticle-based cancer therapeutic, covering formulation strategy, regulatory considerations, and commercialization potential .

• Understand cancer nanotechnology fundamentals, including how to select, differentiate, and utilize specific nanoparticle platforms for targeted drug delivery and precision diagnostics.
• Learn to interpret critical nanoparticle data, including particle size, zeta potential, morphology, encapsulation efficiency, and drug release profiles.
• Evaluate FDA-approved nanomedicines and clinical case studies while analyzing the core challenges of biosafety, regulatory approval, and commercialization.
• Develop a strategic bench-to-bedside roadmap, gaining actionable expertise directly applicable to the pharmaceutical, biotech, and precision healthcare industries.

This workshop is tailored for academic researchers—including undergraduate, postgraduate, Ph.D., and postdoctoral scholars, alongside faculty members—as well as scientists and professionals across biotechnology, nanotechnology, pharmaceutical sciences, biomedical engineering, clinical research, drug discovery, and oncology. It is equally valuable for R&D specialists from industry, research organizations, and national laboratories, medical device and diagnostic professionals, healthcare practitioners interested in precision medicine, and entrepreneurs or innovators driving nanomedicine and healthcare technologies.